F 0645
PASARR screening for Mental disorders or Intellectual Disabilities
Level of Harm - Minimal harm
or potential for actual harm
Based on record review, interview, and facility policy review, the facility failed to ensure a Level I
Preadmission Screening and Resident Review (PASRR) accurately reflected the presence of a diagnosed
mental disorder for 1 (Resident #44) of 5 residents reviewed for PASRR requirements.
Residents Affected - Few
Findings included:
An undated facility policy titled, Preadmission Screening and Resident Review revealed, Purpose: To
ensure that all facility applicants are screened for mental illness and/or intellectual disability and to ensure
coordination with the appropriate state agencies if indicated. The policy specified, II. The Facility, ensures
that PASRR Level I is completed either by the transferring general acute care hospital (GACH), or by the
Facility for all applicants, regardless of Payor source, prior to admission to determine if they have a serious
mental illness (SMI) and/or intellectual disability, developmental disability or related condition(s)
(ID/DD/RC).
An admission Record revealed the facility admitted Resident #44 on 06/04/2024. According to the
admission Record, the resident had a medical history that included a diagnosis of major depressive
disorder, with an onset date of 06/04/2024.
An admission Minimum Data Set (MDS), with an Assessment Reference Date (ARD) of 06/08/2024,
revealed Resident #44 had a Brief Interview for Mental Status (BIMS) score of 12, which indicated the
resident had moderate cognitive impairment. The MDS indicated the resident had an active diagnosis of
depression.
Resident #44's care plan included a Focus area initiated on 06/05/2024, that indicated the resident
exhibited negative mood/behaviors related to depression. A Focus area, initiated on 06/06/2024, indicated
the resident received citalopram (an antidepressant medication) related to a diagnosis of mental illness,
specifically depression.
Resident #44's Preadmission Screening and Resident Review (PASRR) Level I Screening, dated
06/03/2024, revealed the resident's diagnosis of major depressive disorder was not reflected. The question
related to whether the resident had a serious diagnosed mental disorder such as depressive disorder,
anxiety disorder, panic disorder, schizophrenia/schizoaffective disorder, or symptoms of psychosis,
delusions, and/or mood disturbance was answered no, resulting in a negative screening; thus, a Level II
evaluation was not required.
During an interview on 07/25/2024 at 10:54 AM, Medical Records (MR) Staff #1 stated that she was
responsible for reviewing PASRRs completed by the hospital to make sure they were correct. MR Staff #1
said if a resident had a mental illness, it had to be reflected on their PASRR. MR Staff #1 said
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
555870
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555870
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/26/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Bella Vista Health Center
7922 Palm Street
Lemon Grove, CA 91945
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0645
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
she was responsible for submitting another PASRR if the one completed by the hospital was not accurate
and did not reflect all diagnoses.
During an interview on 07/26/2024 at 10:00 AM, the Director of Nursing (DON) stated facility staff pulled
PASRRs from the system but indicated they should be reviewing them for accuracy and updating them if
needed.
During an interview on 07/26/2024 at 10:55 AM, the Administrator stated she expected PASRRs to be
complete and accurate.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555870
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555870
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/26/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Bella Vista Health Center
7922 Palm Street
Lemon Grove, CA 91945
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
Based on observation, interview, and facility policy review, the facility failed to ensure expired medications
and/or biologicals were removed from 1 (Station 1) of 2 medication storage rooms and 1 of 1 central supply
closet.
Findings included:
A facility policy titled, Storage of Medications, revised in 11/2020, indicated, The facility stores all drugs and
biologicals in a safe, secure, and orderly manner. The policy specified, Discontinued, outdated, or
deteriorated drugs or biologicals are returned to the dispensing pharmacy or destroyed.
An observation on 07/24/2024 at 12:07 PM of the medication storage room located on Station 1 revealed a
Nozin Nasal Sanitizer with an expiration date of 03/2024.
During an interview on 07/25/2024 at 12:09 PM, Registered Nurse (RN) #3 stated the Nozin Nasal
Sanitizer was not supposed to be in the medication storage room, because it was expired.
An observation on 07/24/2024 at 12:16 PM of the central supply closet revealed two boxes of Tucks
(medicated pads) with an expiration date of 03/2024.
During an interview on 07/25/2024 at 12:13 PM, the Director of Nursing (DON) said a routine check of
stored medications should be conducted weekly. The DON said when expired medications were found, they
should be discarded. The DON confirmed the Nozin Nasal Sanitizer and two boxes of Tucks should have
been discarded prior to the survey.
During an interview on 07/26/2024 at 10:57 AM, the Administrator said there should be no expired
medications in any medication storage areas. The Administrator stated expired medications should be
removed and disposed of.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555870
If continuation sheet
Page 3 of 3